Legal & General Group’s Ingevity NGVT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $6.04M | Sell |
84,755
-7,592
| -8% | -$519K | ﹤0.01% | 1409 |
|
|
2025
Q4 | $5.47M | Sell |
92,347
-7,212
| -7% | -$391K | ﹤0.01% | 1513 |
|
|
2025
Q3 | $5.49M | Sell |
99,559
-3,459
| -3% | -$180K | ﹤0.01% | 1524 |
|
|
2025
Q2 | $4.44M | Buy |
103,018
+2,694
| +3% | +$104K | ﹤0.01% | 1605 |
|
|
2025
Q1 | $3.97M | Sell |
100,324
-3,399
| -3% | -$150K | ﹤0.01% | 1632 |
|
|
2024
Q4 | $4.23M | Buy |
103,723
+3,325
| +3% | +$138K | ﹤0.01% | 1659 |
|
|
2024
Q3 | $3.92M | Buy |
100,398
+2,035
| +2% | +$81.1K | ﹤0.01% | 1686 |
|
|
2024
Q2 | $4.3M | Buy |
98,363
+1,737
| +2% | +$83.9K | ﹤0.01% | 1597 |
|
|
2024
Q1 | $4.61M | Buy |
96,626
+541
| +0.6% | +$24.3K | ﹤0.01% | 1559 |
|
|
2023
Q4 | $4.54M | Sell |
96,085
-1,144
| -1% | -$47.5K | ﹤0.01% | 1565 |
|
|
2023
Q3 | $4.63M | Sell |
97,229
-3,814
| -4% | -$208K | ﹤0.01% | 1489 |
|
|
2023
Q2 | $5.88M | Buy |
101,043
+44,773
| +80% | +$2.69M | ﹤0.01% | 1367 |
|
|
2023
Q1 | $4.02M | Buy |
56,270
+2,141
| +4% | +$170K | ﹤0.01% | 1529 |
|
|
2022
Q4 | $3.81M | Sell |
54,129
-438
| -0.8% | -$30.9K | ﹤0.01% | 1557 |
|
|
2022
Q3 | $3.31M | Sell |
54,567
-110,060
| -67% | -$7.38M | ﹤0.01% | 1597 |
|
|
2022
Q2 | $10.4M | Buy |
164,627
+6,633
| +4% | +$432K | ﹤0.01% | 1061 |
|
|
2022
Q1 | $10.1M | Buy |
157,994
+12,455
| +9% | +$833K | ﹤0.01% | 1152 |
|
|
2021
Q4 | $10.4M | Buy |
145,539
+10,857
| +8% | +$826K | ﹤0.01% | 1181 |
|
|
2021
Q3 | $9.61M | Buy |
134,682
+82,541
| +158% | +$6.51M | ﹤0.01% | 1203 |
|
|
2021
Q2 | $4.24M | Sell |
52,141
-9,455
| -15% | -$760K | ﹤0.01% | 1618 |
|
|
2021
Q1 | $4.65M | Sell |
61,596
-7,607
| -11% | -$554K | ﹤0.01% | 1593 |
|
|
2020
Q4 | $5.24M | Buy |
69,203
+1,424
| +2% | +$92.7K | ﹤0.01% | 1435 |
|
|
2020
Q3 | $3.35M | Buy |
67,779
+1,141
| +2% | +$64.4K | ﹤0.01% | 1535 |
|
|
2020
Q2 | $3.5M | Buy |
66,638
+7,396
| +12% | +$351K | ﹤0.01% | 1471 |
|
|
2020
Q1 | $2.32M | Buy |
59,242
+5,215
| +10% | +$305K | ﹤0.01% | 1518 |
|
|
2019
Q4 | $4.72M | Buy |
54,027
+2,267
| +4% | +$198K | ﹤0.01% | 1395 |
|
|
2019
Q3 | $4.39M | Buy |
51,760
+6,415
| +14% | +$572K | ﹤0.01% | 1360 |
|
|
2019
Q2 | $4.77M | Buy |
45,345
+712
| +2% | +$71.5K | ﹤0.01% | 1297 |
|
|
2019
Q1 | $4.71M | Sell |
44,633
-55,575
| -55% | -$5.58M | ﹤0.01% | 1209 |
|
|
2018
Q4 | $8.34M | Buy |
100,208
+2,087
| +2% | +$189K | 0.01% | 883 |
|
|
2018
Q3 | $9.99M | Buy |
98,121
+6,755
| +7% | +$652K | 0.01% | 869 |
|
|
2018
Q2 | $7.4M | Buy |
91,366
+4,664
| +5% | +$371K | 0.01% | 958 |
|
|
2018
Q1 | $6.34M | Buy |
86,702
+1,708
| +2% | +$128K | ﹤0.01% | 992 |
|
|
2017
Q4 | $5.99M | Buy |
84,994
+2,205
| +3% | +$159K | ﹤0.01% | 992 |
|
|
2017
Q3 | $5.17M | Buy |
82,789
+1,608
| +2% | +$95.2K | ﹤0.01% | 1010 |
|
|
2017
Q2 | $4.65M | Buy |
81,181
+6,020
| +8% | +$354K | ﹤0.01% | 1024 |
|
|
2017
Q1 | $4.58M | Sell |
75,161
-16,214
| -18% | -$917K | ﹤0.01% | 976 |
|
|
2016
Q4 | $5.01M | Sell |
91,375
-103,724
| -53% | -$4.97M | ﹤0.01% | 888 |
|
|
2016
Q3 | $9M | Buy |
195,099
+29,976
| +18% | +$1.27M | 0.01% | 682 |
|
|
2016
Q2 | $5.62M | Buy |
+165,123
| New | +$5.16M | 0.01% | 743 |
|
Other funds holding NGVT
VPM
VCM
SBH
SCM
Legal & General Group's NGVT Position: Q1 2026 in Review
Legal & General Group reduced its Ingevity (NGVT) stake by 8.2% in Q1 2026, selling an estimated $519K and leaving 84,755 shares worth $6.04M. The position accounts for ﹤0.01% of the portfolio, ranked #1409.
Legal & General Group first reported a position in NGVT in Q2 2016 and has held it in 40 quarters since. The position peaked at $10.4M in Q4 2021. 307 funds tracked by Wall St. Rank hold NGVT as of Q1 2026.
- Legal & General Group held 84,755 shares of Ingevity worth $6.04M as of Q1 2026.
- Legal & General Group sold 7,592 Ingevity shares in Q1 2026, an estimated $519K.
- Ingevity made up ﹤0.01% of Legal & General Group's portfolio in Q1 2026, its #1409 holding.
- Legal & General Group first reported a position in Ingevity in Q2 2016 and has held it in 40 quarters since.
- Legal & General Group's Ingevity position peaked at $10.4M in Q4 2021.
- 307 funds tracked by Wall St. Rank held Ingevity as of Q1 2026.
Based on Legal & General Group's 13F filing for Q1 2026, filed 8 May 2026.